ICOPE INTENSE-K Pilot Study

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Ageing

In brief

ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.

Key facts

Study ID
NCT07048860
Run by
University Hospital, Toulouse
People needed
40
Starts
2025-07-09
Expected to finish
2025-12-31
Last updated by the study team
2025-07-23

Who can join

Age: 65 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.